Gujarat Themis Biosyn Ltd
BSE:506879
Gujarat Themis Biosyn Ltd
Capital Expenditures
Gujarat Themis Biosyn Ltd
Capital Expenditures Peer Comparison
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Gujarat Themis Biosyn Ltd
BSE:506879
|
Capital Expenditures
-₹538.3m
|
CAGR 3-Years
-198%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Capital Expenditures
-₹27.4B
|
CAGR 3-Years
-30%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Cipla Ltd
NSE:CIPLA
|
Capital Expenditures
-₹13.5B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Capital Expenditures
-₹19.7B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Capital Expenditures
-₹9.1B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Capital Expenditures
-₹4.5B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Gujarat Themis Biosyn Ltd's Capital Expenditures?
Capital Expenditures
-538.3m
INR
Based on the financial report for Dec 31, 2023, Gujarat Themis Biosyn Ltd's Capital Expenditures amounts to -538.3m INR.
What is Gujarat Themis Biosyn Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 3Y
-198%
Over the last year, the Capital Expenditures growth was -155%. The average annual Capital Expenditures growth rates for Gujarat Themis Biosyn Ltd have been -198% over the past three years .